Literature DB >> 6255202

DNA nucleotide sequence heterogeneity between the Towne and AD169 strains of cytomegalovirus.

R F Pritchett.   

Abstract

The results of reciprocal DNA-DNA reassociation kinetics indicated that although the DNAs of human cytomegalovirus (CMV) strains Towne and AD169 shared approximately 90% of their nucleotide sequences, about 10% heterogeneity did exist. The implication was that, with respect to one another, the DNAs of CMV Towne and CMV AD169 contained unique nucleotide sequences. To obtain more direct evidence, 32P-labeled DNA of one virus strain was reassociated in the presence of excess unlabeled DNA of the heterologous virus strain. Those 32P-labeled DNA sequences remaining single stranded were separated from double-stranded DNA on hydroxyapatite columns and incubated with Southern blots containing XbaI restriction enzyme fragments of the homologous virus DNA. This approach not only enriched for nucleotide sequences unique to each strain of virus, but also provided for the identification of the restriction enzyme fragments in which the unique sequences were contained. The CMV Towne unique sequences were found in XbaI fragments A, C, G, L, N, and Q of CMV Towne DNA. The CMV AD169 unique sequences were found in XbaI fragments A, C, G, and J of CMV AD169 DNA. The possible significance of these data with respect to variation among other CMV isolates is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255202      PMCID: PMC353626     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies.

Authors:  I Sarov; I Abady
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

2.  Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency.

Authors:  D W Reynolds; S Stagno; K G Stubbs; A J Dahle; M M Livingston; S S Saxon; C A Alford
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

3.  Neutralizing antibodies to cytomegaloviruses in normal simian and human sera.

Authors:  Y Minamishima; B J Graham; M Benyesh-Melnick
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

4.  Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis.

Authors:  D J Lang
Journal:  Arch Gesamte Virusforsch       Date:  1972

Review 5.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

6.  Cytomegalovirus infections in newborn infants.

Authors:  G Birnbaum; J I Lynch; A M Margileth; W M Lonergan; J L Sever
Journal:  J Pediatr       Date:  1969-11       Impact factor: 4.406

7.  Preparation of specific antisera to cytomegaloviruses in goats.

Authors:  H G Haines; R Von Essen; M Benyesh-Melnick; J L Melnick
Journal:  Proc Soc Exp Biol Med       Date:  1971-12

8.  Spectrum of human cytomegalovirus complement-fixing antigens.

Authors:  G R Dreesman; M Benyesh-Melnick
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

9.  Enzymatic synthesis of deoxyribonucleic acid. XXXII. Replication of duplex deoxyribonucleic acid by polymerase at a single strand break.

Authors:  R B Kelly; N R Cozzarelli; M P Deutscher; I R Lehman; A Kornberg
Journal:  J Biol Chem       Date:  1970-01-10       Impact factor: 5.157

10.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

View more
  10 in total

1.  Quantitative PCR determination of human cytomegalovirus in blood cells.

Authors:  J Satou; T Funato; N Satoh; Y Abe; K K Ishii; T Sasaki; M Kaku
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection.

Authors:  Kevin A Cassady
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Mapping and expression of a human cytomegalovirus major viral protein.

Authors:  M G Davis; E C Mar; Y M Wu; E S Huang
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

4.  Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169.

Authors:  J A Nelson; B Fleckenstein; D A Galloway; J K McDougall
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

5.  Structure of the transforming region of human cytomegalovirus AD169.

Authors:  J A Nelson; B Fleckenstein; G Jahn; D A Galloway; J K McDougall
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  Genome structure and virion polypeptides of the primate herpesviruses Herpesvirus aotus types 1 and 3: comparison with human cytomegalovirus.

Authors:  A Ebeling; G Keil; B Nowak; B Fleckenstein; N Berthelot; P Sheldrick
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  Strain-dependent differences in the human cytomegalovirus replication origin.

Authors:  Z Chen; S Watanabe; N Yamaguchi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipients.

Authors:  S A Cassol; M C Poon; R Pal; M J Naylor; J Culver-James; T J Bowen; J A Russell; S A Krawetz; R T Pon; D I Hoar
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

9.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Authors:  T A Cha; E Tom; G W Kemble; G M Duke; E S Mocarski; R R Spaete
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation.

Authors:  F Stéphan; D Méharzi; S Ricci; A Fajac; F Clergue; J F Bernaudin
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.